QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient

PLoS neglected tropical diseases

Volumn 11, Issue 12, 2017, Pages e0006034-

  Chinello, Pierangelo ^a   Petrosillo, Nicola ^a   Pittalis, Silvia ^a   Biava, Gianluigi ^a   Ippolito, Giuseppe ^a   Nicastri, Emanuele ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ANTIVIRUS AGENT; FAVIPIRAVIR; LEVOFLOXACIN; PYRAZINE DERIVATIVE; RNA DIRECTED RNA POLYMERASE;

ADULT; ANTAGONISTS AND INHIBITORS; CASE REPORT; CHEMICALLY INDUCED; DRUG EFFECTS; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HUMAN; ITALY; MALE; PATHOGENICITY; VIROLOGY; VIRUS REPLICATION;

ADULT; AMIDES; ANTIVIRAL AGENTS; ARRHYTHMIAS, CARDIAC; EBOLAVIRUS; ELECTROCARDIOGRAPHY; HEMORRHAGIC FEVER, EBOLA; HUMANS; ITALY; LEVOFLOXACIN; MALE; PYRAZINES; RNA REPLICASE; VIRUS REPLICATION;

EID: 85041273612     PISSN: None     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0006034     Document Type: Article

References (0)